GSK Cuts 641 Jobs in Vaccine Manufacturing Restructuring
We haven't written up this one. Yahoo Finance has the full story — the link below goes straight to it.
More in Health & Medicine
As Europe retreats on pesticides, South Africa has a choice
As the European Union reconsiders pesticide safeguards, South Africa has a crucial window to reform its nearly 80-year-old regulatory framework and protect public health and children's development.
Why most emergency headache patients disappear into the data
Thousands of people visit emergency departments with headaches every year, but research suggests the way these visits are recorded may be hiding important clues about patients' needs.
Axoltis says its Phase 2 study for an experimental ALS drug failed
The French biotech Axoltis Pharma reported a Phase 2 failure in ALS on Tuesday morning, but suggested it found a small signal to move the drug forward amid a noisy dataset.
FDA leaders say they've woven feedback into new trial pilot
The FDA’s long-awaited expedited investigational new drug pilot program began accepting applications Tuesday, with top agency officials incorporating public feedback into who should qualify.
Research updates, September 15
Repeat SARS-C0V-2 infections were linked to a higher odds of new health conditions, according to a new study in the Canada Communicable Disease Report.
STAT+: Medicare to expand its pilot that pays for technology to manage chronic diseases
A recently-launched Medicare experiment that pays for technology to help people manage chronic conditions is expanding.